Back

Is extraplatelet production of thromboxane B2 in acute myocardial infarction the explanation for higher rates of adverse cardiovascular events ?

30 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 6 - Antiplatelet therapy Thrombosis and platelets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Edyta Stodolkiewicz-Nowarska

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

22 More presentations in this session

Presentation thumbnail
Doctor M. Kim (Daejeon, KR)
Abstract
Presentation thumbnail
Mrs V. Rabani (Besancon, FR)
Abstract Slides
Presentation thumbnail
Doctor Y. Katayama (Wakayama, JP)
Abstract Slides
Presentation thumbnail
Doctor S. Fournier (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Mr G. Vos (Nieuwegein, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 6 - Antiplatelet therapy

The Event

Event poster

ESC Congress 2016

30 August 2016 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources